leadf
logo-loader
viewEden Research PLC

Eden Research set to enter period of “strong product sales growth”, says Cenkos

In a note initiating the biopesticide firm at ‘buy’, the broker said the company’s underlying market was expected to grow to around US$9bn by the early 2020s

Eden Research - Eden Research set to enter period of “strong product sales growth”, says Cenkos

Eden Research PLC (LON:EDEN) is set to enter a period of “strong product sales growth” as it expands into new countries and markets, according to analysts at Cenkos Securities.

In a note initiating the biopesticide firm at ‘buy’, the broker said the company’s underlying market was expected to grow at a “high-teen rate” amid increasing global demand for food, reaching a value of around US$9bn by the early 2020s as opposed to US$5bn currently.

WATCH: Eden Research gets 'emergency use' green light for Mevalone in France

Combined with a “favourable regulatory market”, particularly in the US, and the recent banning of several chemical pesticides, Cenkos said Eden represented a “relatively unique opportunity to participate in a developing, growth market”.

Cenkos has forecast revenues of £2mln for Eden in the 2019 financial year, rising to £3.6mln in 2020 and then £6.6mln in 2021.

However, analysts said they had forecast the company’s figures “conservatively”, and saw the potential for Eden to deliver 2019 revenues of up to £3.5mln depending on various outcomes including “upfront payments, milestones and sales currently dependent upon regulatory approval”.

In late-afternoon trading on Wednesday, Eden shares were 3% lower at 9.8p.

Quick facts: Eden Research PLC

Price: 7.125 GBX

AIM:EDEN
Market: AIM
Market Cap: £27.1 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eden Research PLC named herein, including the promotion by the Company of Eden Research PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Cabral Gold adds 2nd drill rig as company identifies new high-grade veins

Cabral Gold (CVE: CBR-OTC: CBGZF) CEO Alan Carter joined Steve Darling from Proactive Vancouver with news the company has identified at least six new NE trending high-grade veins in the Machichie SW area located immediately north of the MG deposit. Carter telling Proactive what had led them...

2 days, 6 hours ago

2 min read